5 trends tracked about this subject — the full history, oldest to newest below.
9 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
Sanofi is scrapping plans for an eczema drug derived from its billion-dollar Kymab acquisition following a strategic pipeline review.
A Johns Hopkins surgeon reveals an AI breakthrough capable of detecting pancreatic cancer earlier than human physicians.
Sanofi's Sarclisa becomes the first cancer drug to receive FDA approval for delivery via a wearable on-body injector for multiple myeloma patients.
6 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.